Quest Diagnostics Inc（DGX）の株価予測DGXQuest Diagnostics Inc

Alphio's DGX stock price prediction model matches the current Quest Diagnostics Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $235.56 (+0.24%). The 1-week path is $235.96 (+0.41%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.

Quest Diagnostics Inc is currently priced at $230.97, which is below the average analyst price target of $250 to $260, suggesting potential upside. However, the stock has an RSI of 44.641, indicating it is nearing oversold territory, but not yet a strong buy signal. The recent announcement of a 15% cut in lab reimbursement rates by CMS poses a significant risk, potentially impacting about 11% of Quest's revenue, which could lead to a decrease in revenue by approximately 1.65% annually. Given these factors, it may be prudent to hold rather than buy at this moment, awaiting clearer signals from upcoming earnings on October 22, 2026.

Quest Diagnostics Inc (DGX) last closed at $235, losing -1.74%. These facts feed the 1-day and 1-week DGX price prediction above.